| Pulse Biosciences, Inc Common Stock (DE) | $2.6b | $48.48 | -0.7% | 94.2K | |
| Arbutus Biopharma Corporation Common Stock | $0.9b | $5.17 | -0.6% | 2.0M | |
| Rani Therapeutics Holdings, Inc. Class A Common Stock | $90.1m | $0.86 | -0.8% | 391.4K | |
| Zentek Ltd. Common Stock | $85.3m | $0.59 | 0.0% | 14.4K | |
| Clene Inc. Common Stock | $64.1m | $4.42 | 0.0% | 16.5K | |
| NanoViricides Inc. | $39.5m | $1.31 | +3.9% | 85.1K | |
| Polyrizon Ltd. Ordinary Shares | $22.1m | $10.80 | +2.1% | 28.5K | |
| Aspire Biopharma Holdings, Inc. Common Stock | $8.4m | $8.57 | +6.1% | 14.7K | |
| TransCode Therapeutics, Inc. Common Stock | $4.5m | $2.65 | +2.2% | 49.8K | |
| Lexaria Bioscience Corp. Common Stock | $0.6m | $11.04 | +4.1% | 6.3K |